Editor’s Note: Today’s issue is a little different from usual…
Chris Wood, editor of Extraordinary Technology, has an exciting new discovery to share with you. It’s a new technology he believes could revolutionize medicine…
On Monday, the Casey Daily Dispatch will return to its regular format.
Delray Beach, Florida
September 18, 2015
It’s 5:00 am on Monday. You wake up feeling awful.
You have a runny nose and a sore throat. And possibly a fever.
You reach for your phone…
But instead of calling your doctor, you grab a swab and rub it inside your cheek.
You insert the swab into a special port on your phone…
Within 30 seconds, your phone reads out your diagnosis:
“You have hay fever, a common allergic response to allergens such as pollen, dust mites, or pet dander.
Hay fever is not contagious. Would you like me to contact your doctor, or recommend any medications that could help with your symptoms?”
• You just had a typical “doctor visit” in the year 2030.
It’s not nearly as farfetched as it sounds. Some doctors are already using a similar technology…
It’s called a “liquid biopsy”… and it’s a game-changer.
I believe liquid biopsies will completely revolutionize medicine in the next couple of years.
And early investors in the right companies could get rich.
Let me explain…
• The basic idea behind a liquid biopsy is simple…
In the 1980s, researchers at Johns Hopkins Medicine found that cancer usually comes from mutations (or changes) to a person’s DNA.
To make a correct diagnosis, doctors need to identify these mutations.
Traditionally, to analyze for mutations, a doctor needed to cut out a piece of a cancer patient’s body. That is a “regular” biopsy.
If your doctor thinks you have lung cancer, for example, he’ll need to cut out a piece of your lung.
A lung biopsy can be painful and dangerous. It could mean days in the hospital.
A study in the Annals of Internal Medicine found that 15% of patients who received a lung biopsy experienced a lung collapse.
Plus, it’s expensive. A lung biopsy costs about $15,000 on average.
• Liquid biopsies solve all these problems…
A liquid biopsy allows a doctor to run the same tests as with a normal biopsy…without cutting into the patient.
Performing a liquid biopsy is easy. A doctor simply takes a small vial of the patient’s blood.
That’s it. It’s easier than giving blood at a blood drive.
It’s WAY less dangerous than a traditional biopsy.
And a lot of evidence shows that a liquid biopsy is better than a traditional biopsy at diagnosing cancer.
Cancer DNA in a patient’s blood contains all the information needed to make a diagnosis.
• Liquid biopsies are better than traditional biopsies in every way…
Liquid biopsies allow a doctor to continually monitor a cancer patient’s progress.
Dr. José Baselga, chief medical officer of Memorial Sloan Kettering Cancer Center, said of liquid biopsies, “I cannot do a weekly liver biopsy and see how things are going, but I can do a blood test every week.”
• This is a huge, life-saving advantage…
We’ve already seen the amazing real-world results.
Philadelphia native Carole Linderman was in remission from breast cancer.
Using a liquid biopsy, her doctor discovered that the cancer had returned and spread to her spine.
This diagnosis happened months before it would have without the liquid biopsy.
“Had this test not been available, we may not have known I had cancer on my spine until symptoms showed up,” Linderman said.
At that point, it may have been too late.
• Liquid biopsies should completely replace dangerous, painful, and expensive traditional biopsies.
This isn’t a long shot. The technology is young, but there’s a lot of evidence to support its promise.
Some of the best doctors in the world believe liquid biopsies could revolutionize medicine…
Dr. Eric Topol, professor of Genomics at The Scripps Research Institute, has said that “Liquid biopsies may soon become the stethoscope for the next 200 years.”
And Dr. Jorge Reis-Filho, surgical pathologist at Memorial Sloan Kettering Cancer Center, said:
The applications of the technology are incredible. There are possibilities to use this technique for disease monitoring, predicting whether patients will relapse or not after receiving a given therapy…
• I believe liquid biopsies are on the cusp of going mainstream…
Not so long ago, an infection like strep throat could easily kill you.
Now that we have antibiotics like penicillin, strep throat will only cause you to miss a day of work.
It’s hard to imagine the world without antibiotics today…
I believe that within a few years, it will be hard to imagine the world without liquid biopsies.
Within five years, you might even get a liquid biopsy at your routine annual physical.
• Investing in the right liquid biopsy company today is like investing in Intuitive Surgical (ISRG) in the year 2000…
Intuitive Surgical developed the first successful surgical robot. It literally changed the way doctors do surgery.
Early investors in Intuitive Surgical got rich. Its stock soared from $18 to $515.
A $10,000 investment in Intuitive Surgical in 2000 is worth over $280,000 today.
• One liquid biopsy company could see gains as big as Intuitive Surgical’s…
This company developed the first fully noninvasive liquid biopsy.
It’s still a very small company…but I don’t expect it to remain small for long.
I think this company’s stock is an easy double over the next two years.
And if it does as well as I expect, it could gain 500% or even 1,000% in the next 10 years.
You can get in on this stock with us by taking a risk-free trial of Extraordinary Technology.
Our generous refund policy allows you to take 90 days to decide if Extraordinary Technology is for you.
If it’s not, no problem. We’ll give you a full refund.
There’s no reason not to try out Extraordinary Technology. Click here to start your risk-free trial today.
P.S. This is just one of the life-changing technologies that Chris and his team are monitoring. They're also following a company that's developing what's being called a possible cure for certain cancers. Click here to get your risk-free trial of Extraordinary Technology today and start making money on these incredible new technologies.